title: Hepatic organic anion transporting polypeptide transporter and thyroid hormone receptor interplay determines cholesterol and glucose homeostasis.
abstract: The role of organic anion transporting polypeptides (OATPs), particularly the members of OATP1B subfamily, in hepatocellular handling of endogenous and exogenous compounds is an important and emerging area of research. Using a mouse model lacking Slco1b2, the murine ortholog of the OATP1B subfamily, we have demonstrated previously that genetic ablation causes reduced hepatic clearance capacity for substrates. In this study, we focused on the physiological function of the hepatic OATP1B transporters. First, we studied the influence of the Oatp1b2 deletion on bile acid (BA) metabolism, showing that lack of the transporter results in a significantly reduced expression of Cyp7a1, the key enzyme of BA synthesis, resulting in elevated cholesterol levels after high dietary fat challenge. Furthermore, Slco1b2-/- mice exhibited delayed clearance after oral glucose challenge resulting from reduced hepatic glucose uptake. In addition to increased hepatic glycogen content, Slco1b2-/- mice exhibited reduced glucose output after pyruvate challenge. This is in accordance with reduced hepatic expression of phosphoenolpyruvate carboxykinase (PEPCK) in knockout mice. We show that this phenotype is due to the loss of liver-specific Oatp1b2-mediated hepatocellular thyroid hormone entry, which then leads to reduced transcriptional activation of target genes of hepatic thyroid hormone receptor (TR), including Cyp7a1 and Pepck but also Dio1 and Glut2. Importantly, we assessed human relevance using a cohort of archived human livers in which OATP1B1 expression was noted to be highly associated with TR target genes, especially for glucose facilitating transporter 2 (GLUT2). Furthermore, GLUT2 expression was significantly decreased in livers harboring a common genetic polymorphism in SLCO1B1.
  
  
  CONCLUSIONS
  Our findings reveal that OATP1B-mediated hepatic thyroid hormone entry is a key determinant of cholesterol and glucose homeostasis.
authors.affiliation: Division of Clinical Pharmacology, Department of Medicine, The University of Western Ontario, London, ON, Canada.
authors.forename: Henriette E
authors.initials: HE
authors.lastname: Meyer zu Schwabedissen
authors.forename: Joseph A
authors.initials: JA
authors.lastname: Ware
authors.forename: David
authors.initials: D
authors.lastname: Finkelstein
authors.forename: Amarjit S
authors.initials: AS
authors.lastname: Chaudhry
authors.forename: Sara
authors.initials: S
authors.lastname: Mansell
authors.forename: Matilde
authors.initials: M
authors.lastname: Leon-Ponte
authors.forename: Stephen C
authors.initials: SC
authors.lastname: Strom
authors.forename: Hani
authors.initials: H
authors.lastname: Zaher
authors.forename: Ute I
authors.initials: UI
authors.lastname: Schwarz
authors.forename: David J
authors.initials: DJ
authors.lastname: Freeman
authors.forename: Erin G
authors.initials: EG
authors.lastname: Schuetz
authors.forename: Rommel G
authors.initials: RG
authors.lastname: Tirona
authors.forename: Richard B
authors.initials: RB
authors.lastname: Kim
mesh_terms: D000818:Animals; D002784:Cholesterol / Q000502:physiology*; D005947:Glucose / Q000502:physiology*; D006706:Homeostasis; D006801:Humans; D051379:Mice; D027361:Organic Anion Transporters / Q000502:physiology*; D011988:Receptors, Thyroid Hormone / Q000502:physiology*
chemical_list: D027361:Organic Anion Transporters; D011988:Receptors, Thyroid Hormone; D002784:Cholesterol; D005947:Glucose